Distinguished in Gillespie Syndrome

Andrea H. Nemeth

Oxford, ENG, GB 
Distinguished in Gillespie Syndrome
Oxford, ENG, GB 
OverviewLocationsClinical Research

Overview

Andrea Nemeth practices in Oxford, United Kingdom. Ms. Nemeth is rated as a Distinguished expert by MediFind in the treatment of Gillespie Syndrome. Her top areas of expertise are Hereditary Ataxia, Drug Induced Dyskinesia, Gillespie Syndrome, Acute Cerebellar Ataxia, and Deep Brain Stimulation.

Her clinical research consists of co-authoring 81 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Gillespie Syndrome.

Gender
Female

Locations

Oxford, ENG, United Kingdom
Other Locations
UCL Great Ormond Street Institute Of Child Health, London, ENG, United Kingdom
National Institute For Health Research Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute Of Child Health, Great Ormond Street Hospital For Children NHS Foundation Trust, The Clinical Genetics Department And St. John's Institute Of Dermatology, Guy's And St. Thomas' NHS Foundation Trust, St. Mary's Hospital, Sheffield, ENG, United Kingdom
Newcastle Upon Tyne, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
Enrollment Status: Terminated
Publish Date: August 04, 2023
Intervention Type: Drug
Study Drug: BIIB132
Study Phase: Phase 1

81 Total Publications

Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).
Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).
Journal: Ophthalmic genetics
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nemeth's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile